Testmiljö
Observera att detta är en testmiljö för utveckling som inte ska användas som underlag för klinisk bedömning. Besök Janusmed här: https://janusmed.se

11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – acenokumarol

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
3 3
3 3

Acenokumarol Testmiljö

Acenokumarol

Klass : 3

Visa all info

Skriv ut

Kontakta oss

  1. Sillesen M, Hjortdal V, Vejlstrup N, Sørensen K. Pregnancy with prosthetic heart valves - 30 years' nationwide experience in Denmark. Eur J Cardiothorac Surg. 2011;40:448-54.

  2. Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J et al. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 2007;197:457.e1-21..

  3. Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 2006;95:949-57.

  4. Cotrufo M, De Feo M, De Santo LS, Romano GP, Della Corte A, Renzulli A et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obset Gynecol 2002;99:35-40.

  5. van Driel D, Wesseling J, Sauer PJ et al. Teratogen update: Fetal effects after in utero exposure to coumarins, overview of cases, follow-up findings, and pathogenesis. Teratology 2002;66:127-40.

  6. Wesseling J, van Driel D, Smrkovsky M, ven der Veer E, Geven-Boere LM, Suer PJ et al. Neurological outcome in school-age children after in utero exposure to coumarins. Early Hum Dev 2001;63:83-95.

  7. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33:1637-41.

  8. Gartner BC, Seifert CB, Michalk DV, Roth B. Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives. Z Geburtshilfe Perinatol 1993;197:262-5.

  9. Iturbe-Alessio I, Fonseca MC, Mutchinik O et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986;315:1390-3.

  10. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122-40.

  11. Barr M, Burdi AR. Warfarin-associated embryopathy in a 17-week-old abortus. Teratology 1976;14:129-34.

  12. Letter: Warfarin and fetal abnormality. Lancet 1976;1:1127.

  1. Sillesen M, Hjortdal V, Vejlstrup N, Sørensen K. Pregnancy with prosthetic heart valves - 30 years' nationwide experience in Denmark. Eur J Cardiothorac Surg. 2011;40:448-54.
  2. Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J et al. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 2007;197:457.e1-21..
  3. Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 2006;95:949-57.
  4. Cotrufo M, De Feo M, De Santo LS, Romano GP, Della Corte A, Renzulli A et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obset Gynecol 2002;99:35-40.
  5. van Driel D, Wesseling J, Sauer PJ et al. Teratogen update: Fetal effects after in utero exposure to coumarins, overview of cases, follow-up findings, and pathogenesis. Teratology 2002;66:127-40.
  6. Wesseling J, van Driel D, Smrkovsky M, ven der Veer E, Geven-Boere LM, Suer PJ et al. Neurological outcome in school-age children after in utero exposure to coumarins. Early Hum Dev 2001;63:83-95.
  7. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33:1637-41.
  8. Gartner BC, Seifert CB, Michalk DV, Roth B. Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives. Z Geburtshilfe Perinatol 1993;197:262-5.
  9. Iturbe-Alessio I, Fonseca MC, Mutchinik O et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986;315:1390-3.
  10. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122-40.
  11. Barr M, Burdi AR. Warfarin-associated embryopathy in a 17-week-old abortus. Teratology 1976;14:129-34.
  12. Letter: Warfarin and fetal abnormality. Lancet 1976;1:1127.